Healthcare Analytics, Population Health Management, Healthcare Big Data

Precision Medicine News

Senate Passes Pediatric Cancer Drug Development Expansion Bill

August 9, 2017 - An update of PREA called the RACE for Children Act (RACE), which would expand the number of pediatric cancer drug treatments in development, passed the US Senate following House approval and heads to the President’s desk for signing. The advocacy group Kids v. Cancer (KvC) announced in a press release how the RACE act can promote positive changes in pediatric cancer research by opening...


Articles

Chan, Zuckerberg Donate $10M to UCSF Precision Medicine Lab

by

Dr. Priscilla Chan and her husband, Facebook founder Mark Zuckerberg, have made a $10 million donation to one of the nation’s leading precision medicine research facilities at UC San Francisco. The UCSF Institute for Computational Health...

IBM Watson, Quest Launch Genomic Cognitive Computing Partnership

by

IBM Watson Health and Quest Diagnostics have announced a new partnership that will bring Watson’s cognitive computing and genomic sequencing capabilities to a larger number of patients nationwide. The launch of “IBM Watson Genomics...

“All of Us” Taps First Community Precision Medicine Partners

by

The “All of Us” precision medicine project is taking another step forward by naming the first set of community partners who will help recruit individuals to participate in the Precision Medicine Initiative’s biobanking program....

Informatics, Machine Learning Accelerate Pharmaceutical Discovery

by

Machine learning, informatics, and artificial intelligence have been making quite a big splash on the clinical side of the healthcare industry during the first half of 2017, but these big data analytics techniques have even broader applications...

Artificial Intelligence, Genomics Combo Boosts Precision Medicine

by

The combination of artificial intelligence and genomic sequencing could significantly accelerate the development of precision medicine, researchers from the New York Genome Center (NYGC), The Rockefeller University, and IBM suggest in a...

FDA to Streamline Regulations in Light of 21st Century Cures Act

by

The sprawling 21st Century Cures Act aims to bring changes to many areas of the healthcare industry, from drug trials and EHR interoperability to precision medicine and telehealth.  While the law does contain specific directions for stakeholders...

NJ Health System Pilots IBM Watson for Oncology Decision Support

by

As the healthcare system’s increasing reliance on digital technologies brings more and more big data into the clinical environment, providers facing some of the most difficult puzzles in diagnostics and treatment are turning to advanced...

Precision Medicine Test for Bacteria May Aid Antibiotic Stewardship

by

Antibiotic stewardship – or the lack thereof – has become a major topic of concern among patient safety advocates as the number of deaths due to antibiotic-resistant infections each year consistently tops 20,000.  While standardized...

CancerLinQ Brings Big Data Insights to Oncology with FDA, NCI Partners

by

Oncology has always required providers to dig deeply into big data about their patients in order to develop treatment plans for some of the deadliest modern diseases. The explosion of interest in precision medicine, the easier availability of...

“All of Us” Precision Medicine Program Enters Beta Testing

by

The first beta test participants in the All of Us Research Program have started to contribute their personal health data to the nation-wide precision medicine program, says Director Eric Dishman. The program, previously known as the PMI Cohort,...

Henry Ford to Launch New Precision Medicine, Cancer Center

by

A new facility in Detroit, MI aims to become a premier destination center for ambulatory cancer treatment, precision medicine, clinical trials and research, and enhanced support services for cancer patients. The Henry Ford Health System broke...

70% of Orgs Planning Precision Medicine Will Deploy Within 2 Years

by

Precision medicine is quickly approaching its mainstream tipping point as organizations pursue the benefits of delivering personalized care to patients.  Nearly 70 percent of healthcare organizations that are planning precision medicine...

CancerLinQ Partners with FDA for Precision Medicine Studies

by

CancerLinQ and the FDA have entered a long-term partnership centered on studying the real-world impacts of precision medicine therapies for cancer care.  Using big data analytics and patient data, the two organizations will monitor newly...

New CancerLinQ Partnership Expands Big Data Analytics Platform

by

The CancerLinQ oncology data repository is steadily expanding its ability to use big data analytics to deliver meaningful clinical decision support to providers at the point of care.  The latest step in its evolution is a newly announced...

EHR, Biobank Data Uncovers Genetics of Personalized Medicine

by

Research led by Vanderbilt University Medical Center (VUMC) and University of Arizona’s College of Pharmacy effectively used EHR and biobank data to create a database that identifies specific genetic traits influencing personalized medicine....

FHIR Can Move Genomics from Prediction to Precision Medicine

by

In just a few short decades, the field of genomics has expanded dramatically, transitioning from a specialized discipline of academic biology into a mainstay of clinical care at academic medical centers, dedicated precision medicine hubs, and...

UVA Gene Mutation Research Method Speeds Precision Medicine

by

A team from the University of Virginia School of Medicine has developed a quicker way to examine the impact of gene mutation on patient health, potentially changing the way cancer labs conduct research into precision medicine and personalized...

EHRs, Value-Based Care Constrain Personalized Medicine Progress

by

Oncologists are eager to embrace the potential of personalized medicine and genetically-driven precision therapies, but face many of the technical, administrative, and reimbursement challenges that afflict their peers in other specialties, finds...

ONC Highlights Its Precision Medicine Initiative Collaborations

by

The Precision Medicine Initiative (PMI) is alive and well at the Office of the National Coordinator, where partnerships with other key government agencies are laying the big data groundwork for more personalized care.  Collaborations with...

X

Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy

no, thanks